Recent Coverage

 

June 7, 2018

The New Yorker
Is the Age-Old Quest for a Baldness Cure Reaching Its End?
Click here to read the full article as it appears in The New Yorker (06/07/18). Read full article

November 22, 2017

Life Science: Investing News Network
RepliCel CEO: Anticipating the Approval of Their Dermal Injector, its Impact in Europe and Beyond
Click here to read the full article as it appears in the Investing Life Science: Investing News Network (11/22/17). Read full article

October 6, 2017

Streetwise Reports The Life Sciences Report
Japan is Fertile Ground for Biotech Deal
Click here to read the full article as it appears in the Streetwise Reports: The Life Sciences Report (10/0/17) Read full article

September 29, 2017

Forbes
Company Uses Patients’ Own Cells To Put An End To Baldness, Aging Skin And Tendon Degeneration
Click here to read the full article as it appears in the Forbes (09/29/17).   Read full article

September 21, 2017

Digital Journal
Regenerative medicine: Interview with a game-changing leader
Regenerative medicine is a game-changing area of medicine. It has the potential to fully heal damaged tissues and organs. To find out more about... Read full article

August 25, 2017

Streetwise Reports
Analyst Says Cell Therapy Company’s Move Decreases Risk
Click here to read the full article as it appears in the Streetwise Reports (08/23/17). Read full article

August 25, 2017

New York Daily News
Your Hair Follicles May Hold the Key to Younger Looking Skin
Click here to read the full article as it appears in the New York Daily News(08/24/17). Read full article

August 9, 2017

DDN News
Skin in the Game
To read the full article as it appears on DDN News (08/08/17), click here. Read full article

July 31, 2017

Financial Post
Why RepliCel May Be the Most Compelling Biotech Company to Watch in Canada
To read the brief and watch the interview provided by Market One Media Group as it appears on the FinancialPost.com, click here. (7/31/17) Read full article

July 14, 2017

BioPharma-Reporter
Hair-Raising R&D: RepliCel Developing Autologous Cell Therapy for Baldness
To read the full article as it appears on BioPharma-reporter.com, click here. (7/12/17) Read full article